Keri Kasun, PharmD's Linkedin Analytics

As an Associate Medical Director at Biogen, I contributed to the medical strategy and execution for the neuromuscular disease portfolio, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). I have over 16 years of tenure in the pharmaceutical industry, supporting complex intrathecal therapeutics in rare neuromuscular diseases and pain management. My clinical and industry experience enables me to build and maintain strong peer-like relationships with thought leaders, clinical investigators, and key stakeholders in the neuromuscular disease community. I also have a strong clinical research acumen in pain and CNS therapeutics, having been involved in multiple clinical trials, publications, and medical education initiatives. My mission is to advance the science and improve the lives of patients with rare diseases of the CNS, leveraging many facets of my broad experience.